Jun 16, 2026 06:48AM
Jun 12, 2026 08:10AM
Jun 11, 2026 08:02AM
Jun 11, 2026 08:01AM
Jun 11, 2026 08:01AM
Jun 11, 2026 08:00AM
May 12, 2026 09:30AM Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting
May 7, 2026 04:05PM
Mar 31, 2026 08:05AM
Mar 31, 2026 08:00AM
Mar 6, 2026 12:51PM
Mar 5, 2026 04:05PM
Feb 4, 2026 08:00AM
Dec 24, 2025 06:00AM Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
Dec 24, 2025 06:00AM
Dec 1, 2025 04:05PM
Nov 13, 2025 04:47AM
Nov 12, 2025 04:05PM
Nov 3, 2025 07:02AM
Nov 3, 2025 07:01AM
Nov 3, 2025 07:00AM Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell T
Nov 3, 2025 07:00AM
Nov 2, 2025 04:00PM
Aug 12, 2025 04:05PM
May 8, 2025 04:05PM
Apr 24, 2025 04:16PM
Apr 24, 2025 04:15PM
Mar 10, 2025 04:05PM Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Jan 12, 2025 07:05PM
Nov 6, 2024 04:05PM
Sep 25, 2024 09:00AM
Sep 4, 2024 07:29AM
Sep 3, 2024 08:01AM
Sep 3, 2024 08:00AM
Aug 12, 2024 08:04AM Caribou Bioscience (CRBU) Appoints Tina Albertson, MD, PhD, as Chief Medical Officer
Aug 12, 2024 08:00AM
Aug 6, 2024 04:05PM
Jul 9, 2024 08:04AM
Jul 9, 2024 08:00AM
Jun 3, 2024 06:25AM
Jun 2, 2024 07:00PM
May 13, 2024 07:00AM Precision BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
May 7, 2024 04:05PM
Apr 27, 2024 06:00AM
Apr 24, 2024 10:00AM
Apr 4, 2024 04:00PM
Apr 4, 2024 04:00PM
Mar 27, 2024 06:45AM
Mar 11, 2024 04:05PM Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Jan 8, 2024 05:19AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All